Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Role of Interleukin 6 in Substance Use Disorder Treatment Failure

The Role of Interleukin 6 in Substance Use Disorder Treatment Failure Abstract Substance use disorders (SUDs) are often misunderstood as a reflection of an individual's lack of motivation or willpower or as a moral failing. SUDs are complex and require a biopsychosocial lens to understand the phenomenon, particularly treatment failure, which is described as a deficit in patients' willpower/self-regulation or dedication to managing their condition. Recent evidence has implicated inflammatory cytokines such as interleukin 6 (IL-6) in the action of substance use by impairing executive functioning, which is an essential aspect of self-regulatory control. Emerging research indicates that inflammation may also shape social behavior, including social withdrawal and approach, thus having potential implications on health-seeking and health-sustaining behaviors often interpreted as a dedication to managing health conditions. The aim of this two-part biobehavioral synthesis is to (a) examine the scientific evidence of the role of IL-6 in self-regulatory failure, (b) explore IL-6 as a common inflammatory mechanism across SUDs, and (c) investigate the role of IL-6 in social withdrawal and approach to gain an understanding of how this determinant may impact treatment failure. Overall, the evidence supports a new paradigm of treatment failure that stresses the influence of IL-6 on self-regulatory failure by way of dual cognitive processing and the role of IL-6 in shaping social behavior central to health-seeking and health-sustaining behaviors. This discovery will help to minimize stigma and blame. Understanding the role of IL-6 in treatment failure may elucidate novel targets for intervention, improve treatment outcomes, and break the social disconnection cycle often seen in SUDs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Addictions Nursing Wolters Kluwer Health

The Role of Interleukin 6 in Substance Use Disorder Treatment Failure

Techau, Aimee
Journal of Addictions Nursing , Volume 33 (4) – Oct 1, 2022
Download PDF
21 pages

Loading next page...
 
/lp/wolters-kluwer-health/the-role-of-interleukin-6-in-substance-use-disorder-treatment-failure-FQmDaZlwML

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 International Nurses Society on Addictions
ISSN
1088-4602
eISSN
1548-7148
DOI
10.1097/jan.0000000000000490
Publisher site
See Article on Publisher Site

Abstract

Abstract Substance use disorders (SUDs) are often misunderstood as a reflection of an individual's lack of motivation or willpower or as a moral failing. SUDs are complex and require a biopsychosocial lens to understand the phenomenon, particularly treatment failure, which is described as a deficit in patients' willpower/self-regulation or dedication to managing their condition. Recent evidence has implicated inflammatory cytokines such as interleukin 6 (IL-6) in the action of substance use by impairing executive functioning, which is an essential aspect of self-regulatory control. Emerging research indicates that inflammation may also shape social behavior, including social withdrawal and approach, thus having potential implications on health-seeking and health-sustaining behaviors often interpreted as a dedication to managing health conditions. The aim of this two-part biobehavioral synthesis is to (a) examine the scientific evidence of the role of IL-6 in self-regulatory failure, (b) explore IL-6 as a common inflammatory mechanism across SUDs, and (c) investigate the role of IL-6 in social withdrawal and approach to gain an understanding of how this determinant may impact treatment failure. Overall, the evidence supports a new paradigm of treatment failure that stresses the influence of IL-6 on self-regulatory failure by way of dual cognitive processing and the role of IL-6 in shaping social behavior central to health-seeking and health-sustaining behaviors. This discovery will help to minimize stigma and blame. Understanding the role of IL-6 in treatment failure may elucidate novel targets for intervention, improve treatment outcomes, and break the social disconnection cycle often seen in SUDs.

Journal

Journal of Addictions Nursing – Wolters Kluwer Health

Published: Oct 1, 2022

References

  • Survey Finds Nearly Three-Quarters (72%) of Americans Feel Lonely
  • Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges
    Audet, M. C.; Jacobson-Pick, S.; Wann, B. P.; Anisman, H.
  • Why Millennials Are Lonely. Retrieved November 24, 2020, from
    Beaton, C.
  • Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients
    Beck, A.; Wüstenberg, T.; Genauck, A.; Wrase, J.; Schlagenhauf, F.; Smolka, M. N.; Heinz, A.
  • Neurocognitive rehabilitation for addiction medicine: From neurophysiological markers to cognitive rehabilitation and relapse prevention
    Campanella, S.
  • Inflammatory response in heroin addicts undergoing methadone maintenance treatment
    Chan, Y. Y.; Yang, S. N.; Lin, J. C.; Chang, J. L.; Lin, J. G.; Lo, W. Y.
  • Stress increases vulnerability to inflammation in the rat prefrontal cortex
    De Pablos, R. M.; Villaran, R. F.; Argüelles, S.; Herrera, A. J.; Venero, J. L.; Ayala, A.; Machado, A.
  • Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways
    Domínguez-Salas, S.; Díaz-Batanero, C.; Lozano-Rojas, O. M.; Verdejo-García, A.
  • Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood
    Eisenberger, N. I.; Inagaki, T. K.; Mashal, N. M.; Irwin, M. R.
  • In sickness and in health: The co-regulation of inflammation and social behavior
    Eisenberger, N. I.; Moieni, M.; Inagaki, T. K.; Muscatell, K. A.; Irwin, M. R.
  • Dual-process theories of higher cognition: Advancing the debate
    Evans, J. S. B.; Stanovich, K. E.
  • Bridging the gap between the neurocognitive lab and the addiction clinic
    Franken, I. H.; van de Wetering, B. J.
  • Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex
    Garcia-Oscos, F.; Peña, D.; Housini, M.; Cheng, D.; Lopez, D.; Borland, M. S.; Salgado-Delgado, R.; Salgado, H.; D’Mello, S.; Kilgard, M. P.; Rose-John, S.; Atzori, M.
  • Experimentally-induced inflammation predicts present focus
    Gassen, J.; Makhanova, A.; Maner, J. K.; Plant, E. A.; Eckel, L. A.; Nikonova, L.; Prokosch, M. L.; Boehm, G. W.; Hill, S. E.
  • Inflammation predicts decision-making characterized by impulsivity, present focus, and an inability to delay gratification
    Gassen, J.; Prokosch, M. L.; Eimerbrink, M. J.; Leyva, R. P.; White, J. D.; Peterman, J. L.; Burgess, A.; Cheek, D. J.; Kreutzer, A.; Nicolas, S. C.
  • Decision biases and persistent illicit drug use: An experimental study of distributed choice and addiction
    Heyman, G. M.; Dunn, B.
  • The role of the ventral striatum in inflammatory-induced approach toward support figures
    Inagaki, T. K.; Muscatell, K. A.; Irwin, M. R.; Moieni, M.; Dutcher, J. M.; Jevtic, I.; Breen, E. C.; Eisenberger, N. I.
  • Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence
    Janes, A. C.; Pizzagalli, D. A.; Richardt, S.; Frederick, B. D.; Chuzi, S.; Pachas, G.; Culhane, M. A.; Holmes, A. J.; Fava, M.; Evins, A. E.; Kaufman, M. J.
  • Investigating the relationships between alcohol consumption, cannabis use, and circulating cytokines: A preliminary analysis
    Karoly, H. C.; Bidwell, L. C.; Mueller, R. L.; Hutchison, K. E.
  • Where there's a will there's a way: A longitudinal investigation of the interplay between recovery motivation and self-efficacy in predicting treatment outcome
    Kelly, J. F.; Greene, M. C.
  • Within-subject associations between inflammation and features of depression: Using the flu vaccine as a mild inflammatory stimulus
    Kuhlman, K. R.; Robles, T. F.; Dooley, L. N.; Boyle, C. C.; Haydon, M. D.; Bower, J. E.
  • The conceptualization of health
    Larson, J. S.
  • Plasma interleukin-6 and executive function in crack cocaine-dependent women
    Levandowski, M. L.; Hess, A. R.; Grassi-Oliveira, R.; de Almeida, R. M.
  • Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions
    Luijten, M.; Machielsen, M. W.; Veltman, D. J.; Hester, R.; de Haan, L.; Franken, I. H.
  • Attentional bias to alcohol stimuli predicts elevated cue-induced craving in young adult social drinkers
    Manchery, L.; Yarmush, D. E.; Luehring-Jones, P.; Erblich, J.
  • Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment
    Marhe, R.; Luijten, M.; Van De Wetering, B. J.; Smits, M.; Franken, I. H.
  • Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers
    Marsland, A. L.; Petersen, K. L.; Sathanoori, R.; Muldoon, M. F.; Neumann, S. A.; Ryan, C.; Flory, J. D.; Manuck, S. B.
  • Drug dependence, a chronic medical disease: Implications for treatment, insurance and outcome evaluation
    McLelland, T.; Lewis, D.; O’Brien, C.; Kleber, H.
  • Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias
    Metrik, J.; Aston, E. R.; Kahler, C. W.; Rohsenow, D. J.; McGeary, J. E.; Knopik, V. S.; MacKillop, J.
  • Inflammatory mechanisms of abused drugs
    Mitchell, C. M.; El Jordi, O.; Yamamoto, B. K.
  • Effects of inflammation on social processes and implications for health
    Moieni, M.; Eisenberger, N. I.
  • Sex differences in depressive and socioemotional responses to an inflammatory challenge: Implications for sex differences in depression
    Moieni, M.; Irwin, M. R.; Jevtic, I.; Olmstead, R.; Breen, E. C.; Eisenberger, N. I.
  • Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10
    Moreira, F. P.; Medeiros, J. R. C.; Lhullier, A. C.; de Mattos Souza, L. D.; Jansen, K.; Portela, L. V.; Oses, J. P.
  • Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback
    Muscatell, K. A.; Moieni, M.; Inagaki, T. K.; Dutcher, J. M.; Jevtic, I.; Breen, E. C.; Irwin, M. R.; Eisenberger, N. I.
  • A triadic neurocognitive approach to addiction for clinical interventions
    Noël, X.; Brevers, D.; Bechara, A.
  • Alcohol-cue exposure effects on craving and attentional bias in underage college-student drinkers
    Ramirez, J. J.; Monti, P. M.; Colwill, R. M.
  • Inflammation, self-regulation, and health: An immunologic model of self-regulatory failure
    Shields, G. S.; Moons, W. G.; Slavich, G. M.
  • Intracellular cytokine production and cognition in healthy older adults
    Simpson, E. E.; Hodkinson, C. F.; Maylor, E. A.; McCormack, J. M.; Rae, G.; Strain, S.; Alexander, H. D.; Wallace, J. M.
  • The association between systemic inflammation and cognitive performance in the elderly: The Sydney Memory and Ageing Study
    Trollor, J. N.; Smith, E.; Agars, E.; Kuan, S. A.; Baune, B. T.; Campbell, L.; Samaras, K.; Crawford, J.; Lux, O.; Kochan, N. A.; Brodaty, H.; Sachdev, P.